S-3 EX-FILING FEES 0001553643 N/A N/A 0001553643 1 2026-03-21 2026-03-21 0001553643 2026-03-21 2026-03-21 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-3

Relmada Therapeutics, Inc.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule
  Amount Registered   Proposed Maximum Offering
Price Per Unit
  Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Common Stock, par value $0.001 per share   (1)   Other   33,685,096   $ 6.41   $ 215,921,465.36   0.0001381   $ 29,818.75
                                           
Total Offering Amounts:   $ 215,921,465.36         29,818.75
Total Fees Previously Paid:               0.00
Total Fee Offsets:               0.00
Net Fee Due:             $ 29,818.75

__________________________________________
Offering Note(s)

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares of common stock being registered hereunder include such indeterminate number of shares of common stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act based on a per share price of $6.41, the average of the high $6.53 and low $6.28 reported sales prices of the registrant’s common stock on the Nasdaq Capital Market on March 30, 2026.